Ziath — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Ziath is a specialized provider of hardware and software for sample management, focusing on 2D barcoded tube and rack scanning. Its technology is designed to simplify inventory control and tracking in biobanking, liquid handling, and research workflows for pharma, biotech, and academia. Acquired by Azenta Life Sciences in 2023, it now operates as a product division within a larger life sciences tools organization. The company emphasizes robust, integrable products and customer-centric support.

DiagnosticsDrug Delivery

Technology Platform

Camera-based 2D barcode scanning hardware and software for sample tube and rack identification, integrated with laboratory automation and informatics systems.

Opportunities

Growth is driven by increasing laboratory automation, expansion of biobanks, and the industry-wide shift from 1D to 2D barcodes for sample tracking.

Integration into Azenta's global sales and sample management ecosystem provides significant cross-selling and scaling opportunities.

Risk Factors

Key risks include integration challenges post-acquisition into Azenta, competition from larger automation vendors and alternative tracking technologies, and dependence on capital expenditure cycles in the life sciences sector which can be sensitive to economic conditions.

Competitive Landscape

Ziath competes in the sample tracking hardware segment against divisions of large automation companies (e.g., Brooks, Hamilton, Tecan) and specialized scanner manufacturers. Its differentiation lies in its dedicated focus on high-performance 2D barcode reading and a reputation for robust, automation-ready devices.

More companies in Digital Health & Biotech SaaS →More companies in United Kingdom →